Description
What GAZYVA is?
GAZYVA (obinutuzumab) is a CD20-directed cytolytic antibody and is indicated:
• in combination with chlorambucil, for the treatment of patients with previously untreated chronic lymphocytic leukemia.
• in combination with bendamustine followed by GAZYVA monotherapy, for the treatment of patients with follicular
lymphoma (FL) who relapsed after, or are refractory to, a rituximab-containing regimen.
What Obinutuzumab is?
Obinutuzumab is a humanized anti-CD20 monoclonal antibody.It can be used as a first-line treatment for chronic lymphocytic leukemia in combination with chemotherapy or with venetoclax, as a first-line treatment for follicular lymphoma in combination with chemotherapy, and as treatment for relapsed or refractory follicular lymphoma in combination with bendamustine chemotherapy.
Pharma Services and Drug Inquiries
Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.
Please note for the minimum order for Exports is of US$ 300. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.
Complete the form below to receive the no-obligation price quote.
Disclaimer
Note : We do not supply schedule-H (Example – narcotic drug or psychotropic drugs or anabolic steroids) and Anti- Abortion Drugs.
All Trademarks and Brands that appear on the website belong to their respective owners and South Delhi Pharma does not lay any claim on them we only provide Information. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.
